SEC Form 4 · accession 0001144204-18-000530
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard James Colonno
Officer — See Remarks
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2018 | A | 25,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On January 1, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in full on August 1, 2018, assuming the Reporting Person's continuous service through August 1, 2018.
Remarks
EVP & Chief Scientific Officer of Virology Operations; Exhibit List: Exhibit 24.1 - Power of Attorney